Call us directly: +44 (0) 30 0302 0202

Emmanuel Kaye House View Location


A tertiary experience of urethral diverticulectomy: diagnosis, imaging and surgical outcomes  Ockrim JL, Shah PJR, Greenwell TJ. BJU Int. 2009 Jun;103(11):1550-4.


Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers.  Bruyere F, Namdarian B, Corcoran NM, Pedersen J, Ockrim J, Voelzke BB, Mete U, Costello AJ, HovensCM.UrolOncol. 2009 Jan 20. [Epub ahead of print]


A tertiary experience of vesico-vaginal and urethro-vaginal fistula repair: factors predicting success  Ockrim JL, Greenwell TJ, Wood DN, Foley CL, Shah PJR. BJU Int. 2009 Apr;103(8):1122-6. Epub 2009 Jan 20.


Tension free transvaginal (TVT) and transobturator (TOT) tape procedures in women with multiple failed incontinence procedures or complex urogynaecological intervention. Ockrim JL, Shah PJR, Greenwell TJ. BJMSU 2008 Sept;1(2):67-74


Considering the long-term impact of androgen deprivation therapy for prostate cancer: is it timely to reconsider options? Ockrim JL and Abel PD BMJ Editorial 2008;337:a1361    A


urora Kinase B is an independent protective factor in superficial bladder tumours with a dysfunctional G1 checkpoint. Bruyere F, Corcoran NM, Berdjis N, Namdarian B, Pedersen J, Ockrim JL, Voelzke BB, Costello AJ, Hovens CM. BJU Int. 2008 Jul;102(2):247-52. Epub 2008 Jul 1.


Therapy Insight: parenteral estrogen treatment for prostate cancer-a new dawn for an old therapy  Ockrim JL, Lalani E, Abel PD Nat ClinPractOncol. 2006 Oct;3(10):552-63. Review.


Changes in vascular flow during transdermal estradiol therapy for prostate cancer: the dichotomy of early versus delayed effect? Ockrim JL, Lalani E, Aslam M, Stansfield H, Kakkar AK, Abel PD. BJU Int. 2006 Mar;97(3):498-504.


Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism. Ockrim JL, Lalani E, Kakkar AK, Abel PD. J Urol. 2005 Aug;174(2):527-33


Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms: comparison with spinal cord injury patients. Ockrim JL, Laniado ME, Khoubehi B, Renzetti R, FinazziAgrò E, Carter  S and Tubaro A.   BJU Int. 2005 Mar;95(4):587-90.


Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer   Ockrim JL, Lalani E, Banks LM, Svensson WE, Blomley MJ, Patel S, Laniado ME, Carter S and Abel PD J Urol. 2004 Dec;172(6, Part 1 of 2):2203-2207.


Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms.Laniado ME, Ockrim JL, Marronaro A, Tubaro A, Carter S. BJU Int. 2004 Dec;94(9):1283-6.


Transdermal estradiol therapy for advanced prostate cancer–forward to the past?   Ockrim JL, Lalani EN, Laniado ME, Carter SS, Abel PD.J Urol. 2003 May;169(5):1735-7.


A probability based system for combining simple office parameters as a predictor of bladder outflow obstruction. Ockrim JL, Laniado ME, Patel A, Tubaro A, St Clair Carter S. J Urol. 2001 Dec;166(6):2221-5